科源制药拟推2025年限制性股票激励计划

Core Viewpoint - Koyuan Pharmaceutical (301281.SZ) has announced a draft for its 2025 restricted stock incentive plan, aiming to grant a total of 3 million restricted shares, which represents approximately 2.77% of the company's total share capital at the time of the announcement [1] Group 1 - The plan includes an initial grant of 2.4 million restricted shares, with an additional 600,000 shares reserved [1] - The grant price is set at 14.71 yuan per share [1] - The effective period of the incentive plan lasts from the date of the first grant until all granted shares are vested or become invalid, with a maximum duration of 48 months [1]